Literature DB >> 19188382

Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.

Mery Ruíz-Cendoya1, Marçal Mariné, M M Rodríguez, Josep Guarro.   

Abstract

We have evaluated and compared the efficacies of high doses of amphotericin B (AMB; 3 mg/kg of body weight/day), voriconazole (60 mg/kg), and posaconazole (PSC; 100 mg/kg) alone and combined in a murine model of disseminated infection by Fusarium oxysporum. The combination of AMB with PSC showed the best results, prolonging the survival of mice and reducing their organ fungal loads. This combination might constitute a therapeutic option for those infections where monotherapies fail.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19188382      PMCID： PMC2663119          DOI： 10.1128/AAC.01606-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Successful treatment of disseminated fusariosis.

Authors:  C A Rodriguez; J Luján-Zilbermann; P Woodard; M Andreansky; E E Adderson
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

Review 3.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  The emerging role of Fusarium infections in patients with cancer.

Authors:  E Anaissie; H Kantarjian; J Ro; R Hopfer; K Rolston; V Fainstein; G Bodey
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

Review 6.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

7.  The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years.

Authors:  M O Musa; A Al Eisa; M Halim; E Sahovic; M Gyger; N Chaudhri; F Al Mohareb; P Seth; M Aslam; M Aljurf
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

8.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

9.  In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.

Authors:  Montserrat Ortoneda; Javier Capilla; F Javier Pastor; Isabel Pujol; Josep Guarro
Journal:  Diagn Microbiol Infect Dis       Date:  2004-01       Impact factor: 2.803

10.  Combined therapy in treatment of murine infection by Fusarium solani.

Authors:  Mery Ruíz-Cendoya; Marçal Mariné; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2008-05-20       Impact factor: 5.790
View more
  6 in total

Review 1.  [Resistant fungi].

Authors:  M J G T Vehreschild; O A Cornely
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

Review 2.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

3.  Combined therapy against murine-disseminated infection by Fusarium verticillioides.

Authors:  Mery Ruíz-Cendoya; Javier Pastor; Josep Guarro
Journal:  Mycopathologia       Date:  2010-09-18       Impact factor: 2.574

4.  Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; John R Graybill; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

Review 5.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.

Authors:  J Guarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-11       Impact factor: 3.267

Review 6.  Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.

Authors:  Mario Delia; Rosa Monno; Giorgia Giannelli; Amato Antonio Stabile Ianora; Lidia Dalfino; Domenico Pastore; Carmen Capolongo; Carla Calia; Annamaria Tortorano; Giorgina Specchia
Journal:  Mycopathologia       Date:  2016-03-23       Impact factor: 2.574
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.